NeoGenomics Inc (NEO) NPV
Sell:$8.50Buy:$8.96
$0.70
(7.43%)
- This stock can be held in a
Stocks and Shares ISA$0.70
(7.43%)$0.70
(7.43%)Company Information
About this company
NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.
Key people
Key facts
- EPICNEO
- LocationUnited States
- SectorHealthcare
- IndustryHealthcare Facilities
- ISINUS64049M2098
- Market cap$1.20bn
- Employees2,200
- Shares in issue128.46m
- ExchangeNASDAQ
- IndexS&P 600 Small Cap, TR Equity United States Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.